Genotyping of Mycobacterium tuberculosis Rifampin Resistance Associated Mutations Using Data From Xpert® MTB/RIF Ultra Enables Large-Scale Tuberculosis Molecular Epidemiology Studies.
Molecular epidemiology studies of tuberculosis have been empowered in recent years by the availability of whole genome sequencing, which has allowed a new focus on the adaptive significance of drug resistance mutations. Genome sequencing technology remains expensive, however, limiting the potential for larger studies. Conversely, during this same time the GeneXpert® molecular diagnostic has been deployed globally and now serves as a cornerstone of tuberculosis diagnosis and drug sensitivity testing. In this issue of the Journal of Clinical Microbiology, Y. Cao et al. (J Clin Microbiol 57:e00907-19, https://doi.org/10.1128/JCM.00907-19) report the development of an algorithm that can use high-resolution melting temperature data generated in the course of the next generation Xpert® MTB/RIF Ultra assay to accurately genotype rifampin resistance-associated mutations. When paired with a system to aggregate data from diagnostic laboratories, this technique has the potential to enable global-scale studies of the epidemiology of tuberculosis drug resistance.